Details for New Drug Application (NDA): 086485
✉ Email this page to a colleague
NDA 086485 describes THEOPHYL-225, which is a drug marketed by Ortho Mcneil Pharm and is included in two NDAs. Additional details are available on the THEOPHYL-225 profile page.
The generic ingredient in THEOPHYL-225 is theophylline. There are thirty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the theophylline profile page.
The generic ingredient in THEOPHYL-225 is theophylline. There are thirty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 086485
| Tradename: | THEOPHYL-225 |
| Applicant: | Ortho Mcneil Pharm |
| Ingredient: | theophylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 086485
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | ELIXIR;ORAL | Strength | 112.5MG/15ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
